A Phase 1a Study of Thymosin Beta 4 in Healthy Volunteers

NCT04555824 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Recombinant Human Thymosin β4
OTHER: Placebo

Sponsor

Beijing Northland Biotech. Co., Ltd.